Biotech

All Articles

Tracon winds down weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has made a decision to wind down operations full weeks after an injectable i...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on failed epilepsy medication, promotes FDA run

.Our team already recognize that Takeda is actually hoping to discover a pathway to the FDA for epil...

VBI Vaccinations files for personal bankruptcy, seeks possession sale

.Immunology biotech VBI Vaccines is diverting hazardously close to the point of no return, with plan...

Celldex anti-cKIT antibody lessen hives in one more phase 2 study

.It is actually hard to muscular tissue in on an area as reasonable as immunology, but Celldex Thera...

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Therapeutics as well as a prec...

Ventyx's last resort for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's condition medication carried out not aid people obtain remission in a s...

Cognition's stage 2 SHINE information taint Alzheimer's possibility

.Cognition Therapeutics' period 2 luster test has actually taken several of the gloss off the Alzhei...

BMS centers bispecific months after filing to function period 3 trial

.Bristol Myers Squibb has actually possessed a whiplash change of heart on its own BCMA bispecific T...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., that oversaw Mirati Therapeutics' $ 5.8 billion purchase to Bristol Myer...